CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Bluebird Bio, Inc.  (BLUE)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

BLUE's Revenue Year on Year Growth by Quarter and Year

Bluebird Bio,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
BLUE Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 1.55 1.47 6.39
III Quarter September - 1.55 1.32 6.37
II Quarter June - 1.55 4.94 6.34
I Quarter March 6.83 1.50 6.34 6.34
FY   6.83 6.15 14.07 25.44

Financial Statements
Bluebird Bio,'s first quarter 2017 Revenue $ 6.83 millions BLUE's Income Statement
Bluebird Bio,'s first quarter 2016 Revenue $ 1.50 millions Quarterly BLUE's Income Statement
BLUE's Growth by Division See BLUE's Growth by Segment

BLUE Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 5.44 % -77 % -
III Quarter September - 17.42 % -79.28 % 0.63 %
II Quarter June - -68.62 % -22.08 % -
I Quarter March 355.47 % -76.34 % 0 % -
FY   - -56.29 % -44.69 % -



BLUE Revenue Growth Comment
Bluebird Bio, Inc. achieved in the first quarter, above Company average Revenue surge of 355.47% year on year, to $ 6.83 millions.

Looking into first quarter results within Biotechnology & Drugs industry 4 other companies have achieved higher Revenue growth. While Bluebird Bio, Inc.' s Revenue doubling of 355.47% ranks overall at the positon no. 73 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #5
Healthcare Sector #23
S&P 500 #73
Revenue Y/Y Growth Statistics
High Average Low
355.77 % 5.55 % -79.2 %
(Mar 31 2017)   (Sep 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BLUE's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BLUE's Competitors
Revenue Growth for Bluebird Bio,'s Suppliers
Revenue Growth for BLUE's Customers

You may also want to know
BLUE's Annual Growth Rates BLUE's Profitability Ratios BLUE's Asset Turnover Ratio BLUE's Dividend Growth
BLUE's Roe BLUE's Valuation Ratios BLUE's Financial Strength Ratios BLUE's Dividend Payout Ratio
BLUE's Roa BLUE's Inventory Turnover Ratio BLUE's Growth Rates BLUE's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Geovax Labs, Inc.  521.29 %$ 521.292 millions
Cytomx Therapeutics, Inc.  424.20 %$ 424.202 millions
Sientra, Inc.  409.11 %$ 409.109 millions
Sorrento Therapeutics, Inc.  393.32 %$ 393.320 millions
Bluebird Bio, Inc.  355.77 %$ 355.771 millions
Agenus Inc  352.36 %$ 352.365 millions
Protalix Biotherapeutics, Inc.  325.48 %$ 325.479 millions
Lifestyle Medical Network, Inc.  319.44 %$ 319.438 millions
Orexigen Therapeutics, Inc.  280.39 %$ 280.389 millions
Intellia Therapeutics, Inc.  249.75 %$ 249.747 millions
Biolargo, Inc.  230.06 %$ 230.060 millions
Corbus Pharmaceuticals Holdings, Inc.  226.20 %$ 226.199 millions
Exact Sciences Corp  226.01 %$ 226.006 millions
Accelerate Diagnostics, Inc.  225.15 %$ 225.153 millions
Ionis Pharmaceuticals Inc  199.14 %$ 199.138 millions
Immune Design Corp.  193.34 %$ 193.344 millions
Transgenomic Inc  178.81 %$ 178.814 millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
BCDA's Profile
Stock Price
BCDA's Financials
BCDA's Expectations
Business Description
Fundamentals
Charts & Quotes
BCDA's News
Suppliers
BCDA's Competitors
Customers & Markets
Economic Indicators
BCDA's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com